ASH 2018: Expert overview of the latest in CLL, ALL and AML
3 Dec 2018
ASH 2018: Expert overview of the latest in CLL, ALL and AML
Determining the prognosis of patients with myelodysplastic syndromes using machine learning
Link between gut microbiota and haematopoietic cell transplantation outcomes
New therapies for transfusion dependent MDS patients
Cancer care in areas of drug conflict
Cancer control in small island developing states
The best way to collaborate
Developing global curricula for cancer control
Pushing for cost effective interventions in lower and middle income countries
Cancer control in areas of conflict
The value for money of drugs and other tech
Universal health coverage and cancer care